ATE406905T1 - Peptid-erhöhende fusiogene kapazität eines gameten - Google Patents

Peptid-erhöhende fusiogene kapazität eines gameten

Info

Publication number
ATE406905T1
ATE406905T1 AT04805493T AT04805493T ATE406905T1 AT E406905 T1 ATE406905 T1 AT E406905T1 AT 04805493 T AT04805493 T AT 04805493T AT 04805493 T AT04805493 T AT 04805493T AT E406905 T1 ATE406905 T1 AT E406905T1
Authority
AT
Austria
Prior art keywords
capacity
ovocytes
increase
fusiogenic
peptide
Prior art date
Application number
AT04805493T
Other languages
English (en)
Inventor
Morgane Bomsel
Jean-Philippe Wolf
Original Assignee
Univ Paris 13
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris 13, Centre Nat Rech Scient filed Critical Univ Paris 13
Application granted granted Critical
Publication of ATE406905T1 publication Critical patent/ATE406905T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04805493T 2003-11-19 2004-11-19 Peptid-erhöhende fusiogene kapazität eines gameten ATE406905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313545A FR2862225B1 (fr) 2003-11-19 2003-11-19 Peptide augmentant la capacite fusiogene de l'ovocyte

Publications (1)

Publication Number Publication Date
ATE406905T1 true ATE406905T1 (de) 2008-09-15

Family

ID=34508583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805493T ATE406905T1 (de) 2003-11-19 2004-11-19 Peptid-erhöhende fusiogene kapazität eines gameten

Country Status (8)

Country Link
US (2) US8883742B2 (de)
EP (1) EP1684788B1 (de)
AT (1) ATE406905T1 (de)
CA (1) CA2546498C (de)
DE (1) DE602004016371D1 (de)
ES (1) ES2313116T3 (de)
FR (1) FR2862225B1 (de)
WO (1) WO2005051799A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862225B1 (fr) 2003-11-19 2006-06-02 Univ Paris 13 Peptide augmentant la capacite fusiogene de l'ovocyte
FR3041260B1 (fr) * 2015-09-21 2020-10-02 Hopitaux Paris Assist Publique Utilisation d'un tripeptide cyclique pour stimuler l'activite mitochondriale de cellules
WO2019097290A1 (en) * 2017-11-15 2019-05-23 Aratinga.Bio Enhancement of biologics production in cell culture systems by fertilin-derived peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
AU2958195A (en) * 1994-06-29 1996-01-25 Texas Biotechnology Corporation Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
FR2862225B1 (fr) 2003-11-19 2006-06-02 Univ Paris 13 Peptide augmentant la capacite fusiogene de l'ovocyte

Also Published As

Publication number Publication date
CA2546498A1 (fr) 2005-06-09
WO2005051799A2 (fr) 2005-06-09
US20070082839A1 (en) 2007-04-12
US20150051152A1 (en) 2015-02-19
CA2546498C (fr) 2013-04-02
EP1684788A2 (de) 2006-08-02
US9238807B2 (en) 2016-01-19
US8883742B2 (en) 2014-11-11
ES2313116T3 (es) 2009-03-01
DE602004016371D1 (de) 2008-10-16
FR2862225A1 (fr) 2005-05-20
WO2005051799A3 (fr) 2006-04-06
FR2862225B1 (fr) 2006-06-02
EP1684788B1 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
Reinhold et al. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor‐β1 in PWM‐stimulated PBMC and T cells
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
RU2008126743A (ru) Способ получения фармацевтической композиции
CY1108689T1 (el) Ολιγοπεπτιδια για την ελαττωση αυξημενης συγκεντρωσεως της ουριας στο αιμα
CY1112241T1 (el) Θραυσματα πεπτιδιου για διεγερση συνθεσης πρωτεϊνων εξωκυτταρικης μητρας
BRPI0612273A2 (pt) anticorpo de ligaÇço a il-1 beta ou fragmento de ligaÇço a il-1 beta do mesmo, Ácido nucleico, vetor, cÉlula, animal transgÊnico, hibridoma, composiÇço, e, mÉtodos de tratamento ou prevenÇço de uma doenÇa ou doenÇa relacionada a il-1 em um mamÍfero, e de preparaÇço de um polipeptÍdeo de ligaÇço a il-1 beta maturado por afinidade
EP1401473A4 (de) Transporter mit beabstandeten arginin-teilchen
ES2585580T3 (es) Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene
Reed et al. SPARC and the extracellular matrix: implications for cancer and wound repair
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
Hamatani et al. A monoclonal antibody to human SP-10 inhibits in vitro the binding of human sperm to hamster oolemma but not to human Zona pellucida
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
Ullrich et al. Biosynthesis and secretion of an osteopontin-related 20-kDa polypeptide in the Madin-Darby canine kidney cell line
BRPI0412607A (pt) método para aprimorar a eficácia de proteìnas modificantes de reação biológica e muteìnas resultantes
EP1664280A4 (de) Hautregenerationssystem
Ishino et al. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells
DE602004016371D1 (de) Peptid-erhöhende fusiogene kapazität eines gameten
Milligan Guanine nucleotide regulation of the pertussis and cholera toxin substrates of rat glioma C6 BU1 cells
ATE546539T1 (de) Revertierung der negativ-selektiven wirkung von negativen markerproteinen als selektionsverfahren
Basak et al. Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations
Capkova et al. Monoclonal antibody to human sperm acrosomal protein
DE60234847D1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
Sedo et al. Dipeptidyl peptidase IV in two human glioma cell lines
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
Müller Studies on human pathogenic coronaviruses survey for coronaviruses in African bat species and characterization of the novel human coronavirus NL63 (HCoV-NL63) open reading frame 3 (ORF3)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties